Eikon Therapeutics, Inc. (EIKN)
NASDAQ: EIKN · Real-Time Price · USD
9.66
-1.05 (-9.77%)
At close: Apr 24, 2026, 4:00 PM EDT
9.40
-0.25 (-2.64%)
After-hours: Apr 24, 2026, 7:30 PM EDT
Eikon Therapeutics Market Cap
Eikon Therapeutics has a market cap or net worth of $522.71 million as of April 24, 2026.
Market Cap
522.71M
Enterprise Value
444.05M
1-Year Change
n/a
Ranking
Category
Stock Price
$9.66
Market Cap Chart
Since the IPO on February 5, 2026, Eikon Therapeutics's market cap has decreased from $971.72M to $522.71M, a decrease of -46.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 522.71M | -9.77% |
| Apr 23, 2026 | 579.28M | -7.76% |
| Apr 22, 2026 | 628.01M | -1.19% |
| Apr 21, 2026 | 635.59M | 1.65% |
| Apr 20, 2026 | 625.30M | -2.94% |
| Apr 17, 2026 | 644.25M | 5.87% |
| Apr 16, 2026 | 608.52M | 3.69% |
| Apr 15, 2026 | 586.86M | 2.17% |
| Apr 14, 2026 | 574.41M | 7.50% |
| Apr 13, 2026 | 534.35M | 9.67% |
| Apr 10, 2026 | 487.25M | -0.11% |
| Apr 9, 2026 | 487.79M | -5.16% |
| Apr 8, 2026 | 514.32M | 8.20% |
| Apr 7, 2026 | 475.34M | -6.99% |
| Apr 6, 2026 | 511.07M | -4.65% |
| Apr 2, 2026 | 535.97M | -1.79% |
| Apr 1, 2026 | 545.72M | -4.73% |
| Mar 31, 2026 | 572.79M | 9.30% |
| Mar 30, 2026 | 524.06M | -1.04% |
| Mar 27, 2026 | 529.59M | -6.84% |
| Mar 26, 2026 | 568.46M | -4.88% |
| Mar 25, 2026 | 597.61M | 0.09% |
| Mar 24, 2026 | 597.07M | -5.55% |
| Mar 23, 2026 | 632.16M | -0.93% |
| Mar 20, 2026 | 638.09M | 7.65% |
| Mar 19, 2026 | 592.75M | -6.47% |
| Mar 18, 2026 | 633.78M | -8.57% |
| Mar 17, 2026 | 693.16M | 7.45% |
| Mar 16, 2026 | 645.11M | 4.28% |
| Mar 13, 2026 | 618.66M | -2.72% |
| Mar 12, 2026 | 635.94M | -10.62% |
| Mar 11, 2026 | 711.51M | -5.99% |
| Mar 10, 2026 | 756.86M | -5.97% |
| Mar 9, 2026 | 804.91M | 3.69% |
| Mar 6, 2026 | 776.29M | -1.10% |
| Mar 5, 2026 | 784.93M | -4.09% |
| Mar 4, 2026 | 818.40M | 9.86% |
| Mar 3, 2026 | 744.98M | -7.26% |
| Mar 2, 2026 | 803.29M | 7.98% |
| Feb 27, 2026 | 743.90M | 1.03% |
| Feb 26, 2026 | 736.35M | -8.39% |
| Feb 25, 2026 | 803.83M | -0.07% |
| Feb 24, 2026 | 804.37M | 2.97% |
| Feb 23, 2026 | 781.15M | -2.76% |
| Feb 20, 2026 | 803.29M | -4.00% |
| Feb 19, 2026 | 836.76M | -4.67% |
| Feb 18, 2026 | 877.79M | 3.44% |
| Feb 17, 2026 | 848.63M | 4.45% |
| Feb 13, 2026 | 812.46M | 1.48% |
| Feb 12, 2026 | 800.59M | 2.35% |
| Feb 11, 2026 | 782.23M | 6.62% |
| Feb 10, 2026 | 733.65M | -6.60% |
| Feb 9, 2026 | 785.47M | 0.34% |
| Feb 6, 2026 | 782.77M | -19.44% |
| Feb 5, 2026 | 971.72M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Absci | 607.49M |
| ProKidney | 603.92M |
| Adlai Nortye | 596.40M |
| Zevra Therapeutics | 593.57M |
| Shattuck Labs | 578.20M |
| Prothena Corporation | 577.63M |
| Sutro Biopharma | 577.04M |
| CorMedix | 574.88M |